Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Ketamine for Depression in Parkinson's Disease
Recruiting0 awardsPhase 2
New Haven, Connecticut
This trial will study whether ketamine can help treat depression in people with Parkinson's disease, and will also do brain scans to see how ketamine may be working.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.